Correlation Between Seres Therapeutics and Pasithea Therapeutics
Can any of the company-specific risk be diversified away by investing in both Seres Therapeutics and Pasithea Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Seres Therapeutics and Pasithea Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Seres Therapeutics and Pasithea Therapeutics Corp, you can compare the effects of market volatilities on Seres Therapeutics and Pasithea Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Seres Therapeutics with a short position of Pasithea Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Seres Therapeutics and Pasithea Therapeutics.
Diversification Opportunities for Seres Therapeutics and Pasithea Therapeutics
0.4 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Seres and Pasithea is 0.4. Overlapping area represents the amount of risk that can be diversified away by holding Seres Therapeutics and Pasithea Therapeutics Corp in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Pasithea Therapeutics and Seres Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Seres Therapeutics are associated (or correlated) with Pasithea Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Pasithea Therapeutics has no effect on the direction of Seres Therapeutics i.e., Seres Therapeutics and Pasithea Therapeutics go up and down completely randomly.
Pair Corralation between Seres Therapeutics and Pasithea Therapeutics
Given the investment horizon of 90 days Seres Therapeutics is expected to generate 2.36 times more return on investment than Pasithea Therapeutics. However, Seres Therapeutics is 2.36 times more volatile than Pasithea Therapeutics Corp. It trades about 0.18 of its potential returns per unit of risk. Pasithea Therapeutics Corp is currently generating about -0.24 per unit of risk. If you would invest 70.00 in Seres Therapeutics on August 28, 2024 and sell it today you would earn a total of 19.00 from holding Seres Therapeutics or generate 27.14% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Seres Therapeutics vs. Pasithea Therapeutics Corp
Performance |
| Timeline |
| Seres Therapeutics |
| Pasithea Therapeutics |
Seres Therapeutics and Pasithea Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Seres Therapeutics and Pasithea Therapeutics
The main advantage of trading using opposite Seres Therapeutics and Pasithea Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Seres Therapeutics position performs unexpectedly, Pasithea Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Pasithea Therapeutics will offset losses from the drop in Pasithea Therapeutics' long position.| Seres Therapeutics vs. Syros Pharmaceuticals | Seres Therapeutics vs. Iovance Biotherapeutics | Seres Therapeutics vs. Veracyte | Seres Therapeutics vs. Fate Therapeutics |
| Pasithea Therapeutics vs. Nutriband Warrant | Pasithea Therapeutics vs. MediciNova | Pasithea Therapeutics vs. Eliem Therapeutics | Pasithea Therapeutics vs. Virax Biolabs Group |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Content Syndication module to quickly integrate customizable finance content to your own investment portal.
Other Complementary Tools
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules |